LATS2 and hepatocellular carcinoma: Knockdown of CRNDE enhances adriamycin and cisplatin sensitivity by regulating epigenetic suppression of CUGBP elav-like family member 2 (CELF2) and large tumor suppressor kinase 2 (LATS2) in HCC cell lines.28